Graciela Castro Escarpulli | Biology and Life Sciences | Best Researcher Award

Prof. Dr Graciela Castro Escarpulli, Escuela Nacional de Ciencias Biológicas IPN, Mexico

Prof. Dr. Graciela Castro Escarpulli is a renowned professor and researcher at the National School of Biological Sciences, IPN, specializing in Medical Bacteriology and Molecular Biomedicine. She leads multiple research lines using conventional and molecular methods to identify infectious bacteria. With 145 undergraduate theses, 44 master’s, and 18 doctoral theses directed, her contributions include 114 publications, 33 book chapters, and 342 conference presentations. A pioneer in CRISPR-Cas for bacterial typing, she has received numerous awards, including the IPN Research Award and the Lázaro Cárdenas Medal. She is a member of the National System of Researchers (Level 2) since 2006. 🧬🔬📚🏅

Publication Profile

Orcid

Academic & Research Background

Prof. Dr. Graciela Castro Escarpulli is a distinguished professor and researcher at the National School of Biological Sciences, IPN. With expertise in diagnostic medical bacteriology and molecular biomedicine, she has significantly contributed to the field. Her research focuses on both conventional and molecular methods for identifying bacteria responsible for infectious diseases. Through her leadership, she has driven various research lines, advancing diagnostic techniques and improving public health outcomes. Prof. Dr. Castro Escarpulli’s work continues to have a profound impact on medical microbiology, enhancing our understanding of bacterial infections. 🧬🔬🦠👩‍🔬

Achievements & Recognition

Prof. Dr. Graciela Castro Escarpulli is an accomplished academic with an impressive track record. She has supervised 145 bachelor’s theses, 44 master’s theses, and 18 doctoral theses. With 114 indexed papers, 33 book chapters, and 342 global presentations, her expertise spans multiple disciplines. Prof. Castro Escarpulli holds one international patent and has 849 sequences deposited in NCBI, showcasing her contributions to scientific research. Her work continues to make a significant impact in her field, both through academic achievements and innovation. 📚🎓🌍🧬🔬📑

Awards & Contributions

Prof. Dr. Graciela Castro Escarpulli is a renowned researcher and a pioneer in using the CRISPR-Cas system for bacterial typing. She has received several prestigious awards, including the IPN Research Award, the National Technological Innovation Award, and the Lázaro Cárdenas Medal 🏅. Dr. Castro Escarpulli is highly regarded for her contributions to microbiology and biotechnology 🌱. As a frequent speaker at global conferences 🌍, she continues to influence scientific advancements in her field. Her work exemplifies innovation and dedication to improving scientific understanding, particularly in microbial genetics 🧬.

Research Focus

Prof. Dr. Graciela Castro Escarpulli’s research focuses on microbiology, particularly infectious diseases, and the study of pathogens through advanced genetic analysis techniques. Her work includes the use of massive sequencing to identify unusual bacteria in pyogenic liver abscesses, which may not be detected by classical culture methods. She also explores the genetic makeup of pathogens like Acinetobacter baumannii and Candida spp., as well as antimicrobial resistance in Escherichia coli. Her studies contribute to understanding disease mechanisms, improving diagnostics, and combating antimicrobial resistance. 🔬🦠💉🧬

Publication Top Notes

Massive Sequencing of V3-V4 Hypervariable Region in Pyogenic Liver Abscesses Reveals the Presence of Unusual Bacteria Not Detected by Classical Culture Methods

Multidisciplinary Approach of a Male Case of Imported Malaria, HIV Chronic Infection, and Latent Syphilis

Comprehensive comparative analysis of the periodontal pathogen Porphyromonas gingivalis: exploring the pan-genome, the reconstruction of the gene regulatory network and genome-scale metabolic network

The CRISPR–Cas system in clinical strains of Acinetobacter baumannii: an in-silico analysis

Typing of Candida spp. from Colonized COVID-19 Patients Reveal Virulent Genetic Backgrounds and Clonal Dispersion

Genomic Analysis of Multidrug-Resistant Escherichia coli Strains Isolated in Tamaulipas, Mexico

ESKAPE bacteria characterization reveals the presence of Acinetobacter baumannii and Pseudomonas aeruginosa outbreaks in COVID-19/VAP patients

Disinfection efficacy of ozone on ESKAPE bacteria biofilms: Potential use in difficult-to-access medical devices

Impact of the modification of a cleaning and disinfection method of mechanical ventilators of COVID-19 patients and ventilator-associated pneumonia: One year of experience

Iwona Golonka | Biology and Life Sciences | Hypothesis Achievement Award

Dr Iwona Golonka, Department of Physical Chemistry and Biophysics Pharmaceutical Faculty Wroclaw Medical University, Poland

Iwona Maria Golonka is an assistant professor at Wroclaw Medical University, specializing in Physical Chemistry and Biophysics. She earned her Ph.D. in Chemical Sciences from the University of Wrocław and holds a Master’s degree in Chemistry. With over 15 impactful publications and a research focus on antimicrobial peptides and advanced pharmaceutical methods, her work includes significant national and international collaborations. Notable achievements include awards for her research in antimicrobial compounds and patents for innovative drug delivery methods. She has also contributed to academic lectures and conferences globally. 🧪📚🏅

Education

Dr. Iwona Golonka has been an Assistant Professor at Wroclaw Medical University’s Faculty of Pharmacy since 2003, specializing in Physical Chemistry and Biophysics. With 15 scientific papers boasting a total Impact Factor of 48.378, including a notable 2020 publication with an IF of 9.381, Dr. [Name] has significantly contributed to the field. They also co-authored a script for pharmacy and medical analytics students. Dr. [Name] earned their Ph.D. in Chemical Sciences from the University of Wrocław in 2006, with a focus on coordination chemistry, following a Master’s degree in Chemistry in 1999. 🧪📚🔬

Presentations

Golonka I. has contributed significantly to the field of chemistry through various presentations. At the Chemistry towards Biology 10 conference in Bratislava (2022), she explored peptide stability in monolayers and Langmuir balance applications in pharmaceutical sciences. Earlier, at the Fifth Informal Conference on Reaction Kinetics and Atmosphere Chemistry (2004), she studied the reactions of nitrogen dioxide with propanols and fluorinated derivatives. Her research on EPR characteristics of metal complexes was presented at the 9th Nordic IHSS Symposium (2003), and she investigated the impact of metal ions on free radicals in humic brown coal at ISEB 15 (2001). 🌟🔬📊

Awards

In 2022, the Rector of the Medical University of Gdańsk awarded a diploma for scientific and team achievements of the 1st degree for the synthesis and assessment of new antimicrobial compounds and fluorescent dyes. Individual awards of II degree were received in 2021, 2020, and 2022 for publications in the JCR database. In 2016, received a 1st degree Team Award for work on physicochemical methods in drug development and a distinction in the Eureka! MZD competition for inventing a flotation tablet. Previous accolades include the 2004 Dr. Emil Niedźwirski Scholarship and multiple team awards in 2007, 2010, and 2016. 🏆📜🔬💡

Research focus

Iwona Golonka’s research focuses on the stability and effectiveness of peptides and antioxidants in various matrices. Her work includes evaluating the decay kinetics of antioxidants in black elderberry, studying the impact of peptides on monolayers, and analyzing peptide stability. Key studies involve examining how newly synthesized peptides affect monolayer stability and antibacterial properties. Golonka’s contributions also cover antioxidant properties in cellulose matrices and interactions with phosphatidylinositol monolayers. Her research integrates aspects of biochemistry and material science, aiming to enhance the understanding and application of peptides and antioxidants in health and industry. 🧬🔬🍇